Colicin insensitivity correlates with a higher prevalence of extraintestinal virulence factors among Escherichia coli isolates from skin and soft-tissue infections

Journal of Medical Microbiology

Volumn 61, Issue 6, 2012, Pages 762-765

  Petkovšek, Živa ^a   Žgur Bertok, Darja ^a   Erjavec, Marjanca Starčič ^a  

^a UNIVERSITY OF LJUBLJANA   (Slovenia)

Author keywords

[No Author keywords available]

Indexed keywords

COLICIN; COLICIN 1A; COLICIN 1B; COLICIN A; COLICIN B; COLICIN E1; COLICIN E2; COLICIN E3; COLICIN E4; COLICIN E5; COLICIN E6; COLICIN E7; COLICIN E8 J; COLICIN K; COLICIN M; COLICIN N; COLICIN S4; UNCLASSIFIED DRUG; VIRULENCE FACTOR;

ARTICLE; BACTERIAL STRAIN; BACTERIUM CULTURE; BACTERIUM ISOLATE; CORRELATION ANALYSIS; ESCHERICHIA COLI; NONHUMAN; PHYLOGENY; PRIORITY JOURNAL; SENSITIVITY ANALYSIS; SKIN INFECTION; SOFT TISSUE INFECTION;

ANTI-BACTERIAL AGENTS; ANTIBIOSIS; COLICINS; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTIONS; GENOTYPE; HUMANS; SKIN DISEASES, BACTERIAL; SOFT TISSUE INFECTIONS; VIRULENCE FACTORS;

EID: 84861148190     PISSN: 00222615     EISSN: None     Source Type: Journal    
DOI: 10.1099/jmm.0.037234-0     Document Type: Article

References (30)

1. Arnold, T., Zeth, K. & Linke, D. (2009). Structure and function of colicin S4, a colicin with a duplicated receptor-binding domain. J Biol Chem 284, 6403-6413.
2. Cascales, E., Buchanan, S. K., Duché, D., Kleanthous, C., Lloubè s, R., Postle, K., Riley, M., Slatin, S. & Cavard, D. (2007). Colicin biology. Microbiol Mol Biol Rev 71, 158-229.
3. Feldgarden, M. & Riley, M. A. (1998). High levels of colicin resistance in Escherichia coli. Evolution 52, 1270-1276.
4. Gillor, O., Kirkup, B. C. & Riley, M. A. (2004). Colicins and microcins: the next generation antimicrobials. In Advances in Applied Microbiology, pp. 129-146. Edited by J. W. B. Allen, I. Laskin & M. G. Geoffrey. London/San Diego: Academic Press.
5. Horcajada, J. P., Soto, S., Gajewski, A., Smithson, A., Jiménez de Anta, M. T., Mensa, J., Vila, J. & Johnson, J. R. (2005). Quinolone-resistant uropathogenic Escherichia coli strains from phylogenetic group B2 have fewer virulence factors than their susceptible counterparts. J Clin Microbiol 43, 2962-2964.
6. Johnson, J. R. & Stamm, W. E. (1989). Urinary tract infections in women: diagnosis and treatment. Ann Intern Med 111, 906-917.
7. Johnson, J. R., Gajewski, A., Lesse, A. J. & Russo, T. A. (2003). Extraintestinal pathogenic Escherichia coli as a cause of invasive nonurinary infections. J Clin Microbiol 41, 5798-5802.
8. Johnson, J. R., Kuskowski, M. A., O'bryan, T. T., Colodner, R. & Raz, R. (2005). Virulence genotype and phylogenetic origin in relation to antibiotic resistance profile among Escherichia coli urine sample isolates from Israeli women with acute uncomplicated cystitis. Antimicrob Agents Chemother 49, 26-31.
9. Johnson, J. R., Johnston, B., Clabots, C., Kuskowski, M. A. & Castanheira, M. (2010). Escherichia coli sequence type ST131 as the major cause of serious multidrug-resistant E. coli infections in the United States. Clin Infect Dis 51, 286-294.
10. Marrs, C. F., Zhang, L. & Foxman, B. (2005). Escherichia coli mediated urinary tract infections: are there distinct uropathogenic E. coli (UPEC) pathotypes? FEMS Microbiol Lett 252, 183-190.
11. Masi, M., Vuong, P., Humbard, M., Malone, K. & Misra, R. (2007). Initial steps of colicin E1 import across the outer membrane of Escherichia coli. J Bacteriol 189, 2667-2676.
12. Moet, G. J., Jones, R. N., Biedenbach, D. J., Stilwell, M. G. & Fritsche, T. R. (2007). Contemporary causes of skin and soft tissue infections in North America, Latin America, and Europe: report from the SENTRY Antimicrobial Surveillance Program (1998-2004). Diagn Microbiol Infect Dis 57, 7-13.
13. Nowrouzian, F., Adlerberth, I. & Wold, A. E. (2001). P fimbriae, capsule and aerobactin characterize colonic resident Escherichia coli. Epidemiol Infect 126, 11-18.
14. Nowrouzian, F., Hesselmar, B., Saalman, R., Strannegard, I. L., Aberg, N., Wold, A. E. & Adlerberth, I. (2003). Escherichia coli in infants' intestinal microflora: colonization rate, strain turnover, and virulence gene carriage. Pediatr Res 54, 8-14.
15. Obata-Yasuoka, M., Ba-Thein, W., Tsukamoto, T., Yoshikawa, H. & Hayashi, H. (2002). Vaginal Escherichia coli share common virulence factor profiles, serotypes and phylogeny with other extraintestinal E. coli. Microbiology 148, 2745-2752.
16. Oelschlaeger, T. A., Dobrindt, U. & Hacker, J. (2002). Virulence factors of uropathogens. Curr Opin Urol 12, 33-38.
17. Olesen, B., Scheutz, F., Menard, M., Skov, M. N., Kolmos, H. J., Kuskowski, M. A. & Johnson, J. R. (2009). Three-decade epidemio-logical analysis of Escherichia coli O15: K52: H1. J Clin Microbiol 47, 1857-1862.
18. Parret, A. H. A. & De Mot, R. (2002). Escherichia coli's uropathogenic-specific protein: a bacteriocin promoting infectivity? Microbiology 148, 1604-1606.
19. Petkovšek, Ž., Eleršič, K., Gubina, M., Žgur-Bertok, D. & Starčič Erjavec, M. (2009). Virulence potential of Escherichia coli isolates from skin and soft tissue infections. J Clin Microbiol 47, 1811-1817.
20. Picard, B., Garcia, J. S., Gouriou, S., Duriez, P., Brahimi, N., Bingen, E., Elion, J. & Denamur, E. (1999). The link between phylogeny and virulence in Escherichia coli extraintestinal infection. Infect Immun 67, 546-553.
21. Pugsley, A. P. (1985). Escherichia coli K12 strains for use in the identification and characterization of colicins. J Gen Microbiol 131, 369-376.
22. Rijavec, M. (2010). Virulence factors of uroseptic Escherichia coli strains and possible use of colicins as new antimicrobials against urinary infections. PhD thesis, University of Ljubljana, Ljubljana, Slovenia.
23. Rijavec, M., Budič, M., Mrak, P., Müller-Premru, M., Podlesek, Z. & Žgur-Bertok, D. (2007). Prevalence of ColE1-like plasmids and colicin K production among uropathogenic Escherichia coli strains and quantification of inhibitory activity of colicin K. Appl Environ Microbiol 73, 1029-1032.
24. Riley, M. A. & Gordon, D. M. (1992). A survey of Col plasmids in natural isolates of Escherichia coli and an investigation into the stability of Col-plasmid lineages. J Gen Microbiol 138, 1345-1352.
25. Russo, T. A. & Johnson, J. R. (2000). Proposal for a new inclusive designation for extraintestinal pathogenic isolates of Escherichia coli: ExPEC. J Infect Dis 181, 1753-1754.
26. Russo, T. A. & Johnson, J. R. (2006). Extraintestinal isolates of Escherichia coli: identification and prospects for vaccine development. Expert Rev Vaccines 5, 45-54.
27. Schamberger, G. P., Phillips, R. L., Jacobs, J. L. & Diez-Gonzalez, F. (2004). Reduction of Escherichia coli O157: H7 populations in cattle by addition of colicin E7-producing E. coli to feed. Appl Environ Microbiol 70, 6053-6060.
28. Stahl, C. H., Callaway, T. R., Lincoln, L. M., Lonergan, S. M. & Genovese, K. J. (2004). Inhibitory activities of colicins against Escherichia coli strains responsible for postweaning diarrhea and edema disease in swine. Antimicrob Agents Chemother 48, 3119-3121.
29. Starčǐ Erjavec, M., Rijavec, M., Križan-Hergouth, V., Fruth, A. & Žgur-Bertok, D. (2007). Chloramphenicol- and tetracycline-resistant uropathogenic Escherichia coli (UPEC) exhibit reduced virulence potential. Int J Antimicrob Agents 30, 436-442.
30. Zhang, L. & Foxman, B. (2003). Molecular epidemiology of Escherichia coli mediated urinary tract infections. Front Biosci 8, e235-e244.